Genetek Biopharma

What Genetek Biopharma does

GENETEK BIOPHARMA GmbH is a Berlin-based molecular diagnostics company that designs, manufactures, and sells PCR-based genetic testing kits for human disease diagnostics, forensic human identification, and animal genetics. The company's core technology platform is multiplex polymerase chain reaction (PCR) using Short Tandem Repeat (STR), Insertion/Deletion (InDel), and Sequence-Tagged-Site (STS) markers combined with capillary electrophoresis (CE) fragment analysis. Its aneuploidy detection line, AneuSure, uses Quantitative Fluorescent (QF) PCR with 27-35 markers across chromosomes 13, 18, 21, X, and Y to deliver rapid prenatal diagnosis of trisomies, sex chromosome aneuploidies, and spinal muscular atrophy. A second major product pillar covers human identification and forensic genetics through kits such as GT Detector (CODIS-compatible), GT Detector Globe, GT Detector Paleo (degraded DNA), GT InDel Detector, GT XDetector, and GT YDetector 29. The third pillar covers reproductive and hematological testing via HapScreen disease-specific haplotyping kits (F8, PAH, DMD, HBB), GT AZFScreen for Y-chromosome microdeletion and Klinefelter syndrome, and GT Chimerism Detector for bone-marrow transplant monitoring. A fourth pillar addresses equine genetics through GT Equine, a 22-marker STR parentage-testing kit aligned to ISAG recommendations. The portfolio is completed by proprietary kit accessories including direct-PCR lysis buffers (GT BLB, GT AFLB, GT CVLB) that eliminate DNA extraction, 5- and 6-dye matrix standards (GTM5 v2, GTM6 v2), size standards (GT500, GT600, GTE600), and DNA polymerases. All kits are validated for compatibility with Applied Biosystems 3130/xL, 3500/xL, SeqStudio, and Promega Spectrum Compact CE systems and are analyzed using third-party software (GeneMapper ID, GeneMarker).

Genetek operates a direct B2B sales model: trained laboratory professionals and research institutions order through the company website, with kit sizes of 50, 100, 1,000, and 10,000 reactions and quotation-based pricing for bulk orders. Pricing is not publicly disclosed, payment terms are 30 days net, products are non-returnable, and shipping fees apply outside Germany. Sale to private individuals is explicitly excluded, and all products are labeled for research use only, limiting clinical-grade commercial pathways without further regulatory steps. Distribution relies on a small team (1-10 employees) serving customers across medical genetics and prenatal labs, forensic and paternity laboratories, fertility clinics, transplant centers, and equine breed registries and racing organizations.

The company's commercial posture emphasizes technical validation across large sample cohorts (for example, the GT Equine kit on 3,000+ horsehair samples, AneuSure v2 on 1,000+ fetal samples, GT Chimerism Detector on 200+ HLA-matched samples), compliance with international standards (CODIS, ENFSI, ISAG, EAA/EMQN), and platform interoperability rather than direct clinical sales. Capital structure shows no venture, private equity, or strategic investor signals; the entity is a privately held German GmbH headquartered in Berlin-Adlershof. Recent strategic activity centers on a February 2025 collaboration with Promega to validate GT Equine and GT HapScreen CFTR on the Promega Spectrum Compact CE System, plus ongoing development of GT Equine Extra for ISAG 2023 Comparison Test compliance.

Name

Genetek Biopharma

Legal name

GENETEK BIOPHARMA GmbH

Website

https://genetek-biopharma.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Genetek Biopharma GmbH is a Berlin-based developer of multiplex PCR and capillary electrophoresis kits for prenatal aneuploidy screening, human forensic identification, disease haplotyping, and equine parentage testing, sold direct to laboratory and research-institution customers worldwide.

Ownership category

akta.pro rank

Product category

Molecular Diagnostics & Genetic Testing Kits

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)

akta.pro secondary industries

Genetic & Prenatal Testing Laboratories (HLAFAMAH), Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ), Molecular & Genetic Testing (Breed, Hereditary Disease, Oncology) (HLAMADAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD)

Keywords

• Molecular diagnostics kits
• Forensic human identification
• Prenatal genetic testing
• Animal parentage testing
• PCR reagent kits

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales

Revenue model

1. Diagnostic Kit Sales: Sale of proprietary multiplex PCR diagnostic kits for genetic testing applications including prenatal diagnosis, male infertility screening, and disease detection. Products sold in reaction sizes (50, 100, 1000, 10000 RXN) directly to laboratories.
2. Human Identification Kit Sales: Sale of forensic genetics and human identification kits for STR profiling, including GT Detector, GT Detector Globe, GT Detector Paleo, GT InDel Detector, GT XDetector, and GT YDetector 29 products.
3. Animal Identification Kit Sales: Sale of GT Equine and related animal profiling kits for parentage testing and genetic identification in horses.
4. Kit Accessories and Reagents: Sale of supporting products including DNA polymerases (GT Taq, GT HSTaq), size standards (GT500, GT600, GTE600), matrix standards, electrophoresis reagents, and direct PCR lysis buffers.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

GENETEK BIOPHARMA GmbH develops and sells proprietary multiplex PCR-based genetic diagnostic and identification kits for laboratories and research institutions. The portfolio covers prenatal aneuploidy screening (AneuSure series), haplotyping for single-gene disorders (HapScreen series for F8, PAH, DMD, HBB), Y-chromosome microdeletion detection for male infertility (AZFScreen series), bone marrow transplant chimerism monitoring (GT Chimerism Detector), forensic and kinship human identification (GT Detector family, GT InDel, GT X/Y Detector), equine parentage testing (GT Equine), and supporting reagents/accessories.

Product overview

Genetek Biopharma is a molecular diagnostics and genetic testing company based in Berlin, Germany, offering a comprehensive portfolio of PCR-based kits for human disease diagnosis, infertility testing, human identification/forensics, and animal genetics. The product portfolio centers on multiplex STR and InDel marker-based kits using QF-PCR and capillary electrophoresis technology. Core offerings include: (1) AneuSure QF-PCR aneuploidy detection kits (v2, Plus v2, Extra v2, Extra Plus v2, Max v2, Max Plus v2) for prenatal diagnosis of chromosomal disorders including Down, Edwards, Patau syndromes plus SMA; (2) HapScreen kits for single-gene disorder haplotyping (F8/Hemophilia A, PAH/PKU, DMD, HBB); (3) Male infertility AZFScreen kits (v2, Plus v2) for Y-chromosome microdeletion and Klinefelter detection; (4) GT Chimerism Detector for bone marrow transplant monitoring; (5) Human Identification kits (GT Detector, GT Detector Globe, GT Detector Paleo, GT InDel Detector, GT XDetector, GT YDetector 29) for forensic and parentage testing; (6) GT Equine for horse parentage/identification; (7) Supporting kit accessories including direct PCR lysis buffers (GT BLB, GT AFLB, GT CVLB), matrix standards (GTM5 v2, GTM6 v2), size standards (GT500, GT600, GTE600), and DNA polymerases (GT HSTaq, GT Taq). All products are designed for research use only.

Differentiator

Problem solved

Functional benefit

Products and services

• AneuSure v2 QF-PCR diagnostic kit for rapid prenatal detection of chromosomal aneuploidies including Trisomy 21 (Down Syndrome), Trisomy 18 (Edwards Syndrome), Trisomy 13 (Patau Syndrome), and sex chromosome aneuploidies. Contains 27 STR markers distributed across chromosomes 21, 18, 13, X and Y. Targeted at clinical genetics and prenatal diagnosis laboratories.
• AneuSure Plus v2 Enhanced QF-PCR kit with 29 markers for prenatal aneuploidy detection with additional SMA detection capability through SMN1 and SMN2 exon 7 deletion analysis. Designed for clinical genetics laboratories requiring combined aneuploidy screening and SMA testing.
• AneuSure Extra v2 QF-PCR kit with 33 loci including 8 segmental duplication markers for improved detection of biallelic aneuploidies and Turner Syndrome differentiation. Targeted at clinical genetics laboratories performing comprehensive prenatal screening.
• AneuSure Extra Plus v2 QF-PCR kit with 35 markers including SMA detection (SMN1 exon 7 deletion/conversion) and 8 segmental duplication markers for comprehensive prenatal diagnosis. Designed for clinical genetics and prenatal diagnosis laboratories.
• AneuSure Max v2 Advanced QF-PCR kit with 33 markers including 5 additional STR markers and 3 segmental duplications for enhanced chromosome 21, 18, 13 coverage. Targeted at clinical genetics laboratories requiring expanded marker coverage.
• AneuSure Max Plus v2 Comprehensive QF-PCR kit with 35 markers including SMA detection (SMN1/SMN2 exon 7), 8 markers for chromosome 21, 7 for chromosome 18, 7 for chromosome 13, and 8 X-chromosome markers. Designed for full-coverage prenatal diagnosis.
• GT HapScreen F8 Haplotyping and segregation analysis kit for Factor VIII deficiency (Hemophilia A) detection. Contains 5 linked STR markers flanking the F8 gene plus autosomal STR markers for aneuploidy detection. 16 markers in 5-dye system.
• GT HapScreen PAH Prenatal diagnosis and carrier detection kit for Phenylketonuria (PKU). STR markers for the PAH gene plus chromosomes 21, 18, 13, X for aneuploidy detection.
• GT HapScreen DMD Segregation analysis kit for Duchenne/Becker Muscular Dystrophy (DMD/BMD) detection. Contains 6 STR marker regions flanking the dystrophin gene plus aneuploidy markers.
• GT HapScreen HBB Haplotyping kit for hemoglobin disorders (HBB gene-related conditions) screening and diagnosis. Designed for prenatal and carrier screening in clinical genetics labs.
• GT AZFScreen v2 Y chromosome microdeletion detection kit for AZFa, AZFb, and AZFc regions. Based on EAA/EMQN 2023 Best Practice Guidelines. Contains 29 markers including STS, SD, and STR markers, and also detects Klinefelter Syndrome.
• GT AZFScreen Plus v2 Enhanced AZF microdeletion detection kit with 36 markers including 7 X-chromosome STR markers for accurate Klinefelter Syndrome and other sex chromosome aneuploidies detection.
• GT Chimerism Detector Chimerism detection kit for bone marrow transplant engraftment analysis. 16 STR markers plus AMXY for detecting donor/recipient cell mixture with 5% sensitivity. Validated on more than 200 HLA-matched related donor-recipient samples.
• GT HBA Gap Detector Mutation detection kit for alpha-thalassemia (HBA gene) screening. Targeted at clinical genetics and hematology laboratories.
• GT HTT Detector Huntington Disease detection kit for HTT gene repeat expansion analysis. Targeted at clinical genetics and neurology laboratories.
• GT MD1 Detector Myotonic Dystrophy 1 (DM1) detection kit for CTG trinucleotide repeat expansion in the DMPK gene. Features a color-coded panel for severity interpretation.
• GT Detector Human identification kit with 17 loci (16 autosomal STR markers plus Amelogenin). Contains all 13 CODIS core loci with SE33 for high discrimination power. Validated on more than 1000 samples.
• GT Detector Globe Global human identification kit with expanded STR markers for international databases and forensic applications across jurisdictions.
• GT Detector Paleo Forensic human identification kit optimized for degraded, low-quality, and aged bone DNA. Includes 11 STR markers plus Amelogenin in the 100-300bp size range for challenging samples.
• GT InDel Detector Insertion/Deletion polymorphism-based human identification kit. 30 bi-allelic InDel markers plus AMXY for forensic and kinship analysis. Tested on more than 400 samples.
• GT XDetector X chromosome STR-based human identification kit for kinship analysis and female-specific profiling.
• GT YDetector 29 Y chromosome STR kit with 29 markers for male lineage testing, sexual assault cases, and ancestry studies. AMXY is included for female DNA contamination detection.
• GT Equine Horse genetic profiling and parentage testing kit with 22 STR markers on 17 horse chromosomes. Includes all ISAG-recommended markers plus SRY and AMXY for sex typing, with proprietary allelic ladder and bin sets for standardized allele calling. Validated on more than 3000 horsehair samples.
• GT BLB (Blood Lysis Buffer) Direct PCR blood lysis buffer enabling PCR amplification without DNA extraction. 1µl blood with 4µl BLB per reaction. Tested on more than 200 samples without inhibition.
• GT AFLB (Amniotic Fluid Lysis Buffer) Direct PCR buffer for amniotic fluid samples enabling QF-PCR without DNA extraction.
• GT CVLB (Chorionic Villus Lysis Buffer) Direct PCR buffer for chorionic villus samples enabling molecular analysis without DNA extraction.
• GTM5 v2 Matrix Standard 5-dye spectral calibration standard for GT 5-dye system kits. Labeled with 6-FAM, GT 2907, GT 1803, GT 2712, and GT 500 dyes.
• GTM6 v2 Matrix Standard 6-dye spectral calibration standard for GT 6-dye system kits including AneuSure Extra, AneuSure Max series, and GT Detector Globe.
• GT500 Size Standard Internal size standard with 27 fragments from 60bp to 500bp for precise DNA fragment sizing in capillary electrophoresis applications. Orange fluorescent dye labeled.
• GT600 Size Standard Size standard for fragments in the 60-600bp range for capillary electrophoresis applications.
• GTE600 Size Standard Extended range size standard with 34 fragments (60-630bp) for long fragment analysis including GT MD1 Detector and other repeat-expansion applications.
• GT HSTaq (Hot Start Taq DNA Polymerase) Heat-activated Taq DNA polymerase with 96 kDa molecular weight. Chemically modified, non-antibody bound hot start enzyme for PCR applications.
• GT Taq (Taq DNA Polymerase) Standard Taq DNA polymerase for routine PCR applications.
• GT Powerload Electrophoresis loading buffer for gel electrophoresis applications.
• GT MaxPure Agarose Agarose gel for electrophoresis applications.

Quantifiable outcome

• GT Equine kit validated on more than 3000 horsehair samples
• +3 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature7 records

Partnerships

One partnership is on record.

• PromegacoreTechnology or Integration · 1 February 2025Genetek collaborated with Promega to perform spectral calibration and validate results obtained using the Promega Spectrum Compact CE System. Genetek tested its GT Equine kit for horse identification and GT HapScreen CFTR kit using Promega's Compact Spectrum CE System with Polymer4. Promega validated the performance of Genetek's kits on their platform, confirming compatibility equivalent to other CE systems.

Scale indicators7 records

Recent moves6 records

Expansion highlights4 records

Emerging players

• Biosynex: European diagnostics company active in rapid tests, forensic/parentage testing reagents, and molecular diagnostics. Comparable to Genetek in forensic/parentage and emerging clinical-genetics IVD kit categories, though broader portfolio.
• Genetic Technologies / STRA-brand kit providers: Smaller molecular-diagnostics and consumer-genetics specialists with overlap to Genetek's reproductive-health and clinical-genetics test menu; relevant as a peer for niche IVD kit positioning in the sub-scale segment.

Broad incumbents

• Bio-Rad Laboratories: Global life-science and clinical-diagnostics provider with a strong droplet-digital-PCR and clinical-genetics menu, plus historical presence in STR-based forensic kits. Competes with Genetek in molecular diagnostic reagents and forensic workflows.
• Qiagen: Global leader in molecular diagnostics and sample-preparation technologies with broad IVD assay menus, including prenatal aneuploidy (e.g., Aneuploidy QF-PCR) and forensic STR solutions. Competes with Genetek across most of its diagnostic-kit categories at much larger scale.
• PerkinElmer (Revvity): Diagnostics and life-sciences company offering prenatal screening (NIPS), newborn screening, and genetic-analysis reagents. Adjacent competitor in the prenatal/genetic-diagnostics segment where Genetek's AneuSure line competes.
• Thermo Fisher Scientific (Life Sciences): Diversified life-sciences leader offering AmpFLSTR forensic HID kits, capillary electrophoresis platforms (Applied Biosystems 3500/SeqStudio that Genetek targets), and prenatal/clinical-genetics assays. The dominant incumbent in the CE genetic-analysis workflow Genetek supports.
• Promega Corporation: Major life-sciences tools provider offering forensic STR kits (PowerPlex), genetic analysis reagents, and capillary electrophoresis instrumentation. Overlaps directly in forensic HID and equine/animal ID kits and is a Genetek platform/validation partner per the 2025 collaboration.

Direct peers

• ELITech Group: European IVD specialist with molecular diagnostics kits across prenatal aneuploidy, infectious disease, and clinical chemistry using CE-based fragment analysis. Direct overlap with Genetek's AneuSure prenatal franchise and overall CE/qPCR IVD positioning.
• Devyser Diagnostics: Swedish specialist in IVD kits for hereditary disease, oncology, and transplant monitoring using CE-based fragment analysis. Closely comparable to Genetek in technology (STR/qPCR/CE), customer base (clinical genetics and transplant labs), and product mix (single-gene disorder and chimerism kits).

Regional players

• Eurofins Genomics: European-based provider of genomic services and STR-based genotyping/parentage testing kits, including equine parentage. Comparable in animal-genetics and forensic offerings but anchored in service delivery rather than kit manufacturing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/genetek_berlin
• Facebookfacebook.com/genetekberlin
• LinkedInlinkedin.com/company/genetekbiopharma

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetek Biopharma